Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note issued to investors on Wednesday. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

NASDAQ RKDA opened at $4.40 on Wednesday. The company has a market capitalization of $6.01 million, a PE ratio of -1.03 and a beta of 0.88. The business’s fifty day moving average is $5.37 and its 200 day moving average is $3.99. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $10.31.

Hedge Funds Weigh In On Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences as of its most recent SEC filing. Hedge funds and other institutional investors own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.